KRRO

Korro Bio, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website korrobio.com
Employees(FY) 95
ISIN US5009461089

Performance

-0.66%

-6.35%

+13.43%

+29.93%

-8.89%

YTD

-21.75%

Profile

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of KRRO 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 3 indicating strong downward pressure, while the Oscillators Score of 50 suggests a neutral stance. The Technical Score of 26 further reinforces the bearish outlook, signaling potential challenges ahead for the stock.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of KRRO

Stock Rank

Recent News & Updates

2024-12-09 19:00
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors(Globenewswire)
2024-11-21 03:01
Korro to Participate in Upcoming Investor Conferences(Globenewswire)
2024-11-20 18:30
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency(Globenewswire)
2024-11-13 19:00
Korro to Present at the Jefferies London Healthcare Conference(Globenewswire)
2024-11-12 16:05
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates(GlobeNewswire)
2024-11-12 03:05
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-11-04 07:25
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board(GlobeNewswire)
2024-11-03 18:25
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board(Globenewswire)
2024-10-21 16:15
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.(Investor's Business Daily)
2024-10-16 16:20
Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.(Investor's Business Daily)
2024-09-30 08:00
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society(GlobeNewswire)
2024-09-29 20:00
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society(Globenewswire)
2024-09-16 08:00
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates(GlobeNewswire)
2024-09-15 20:00
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates(Globenewswire)
2024-09-10 08:00
Korro to Participate in Upcoming Investor Conferences(GlobeNewswire)
2024-09-09 20:00
Korro to Participate in Upcoming Investor Conferences(Globenewswire)
2024-09-04 08:08
Will Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?(Simply Wall St.)
2024-08-28 08:00
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors(GlobeNewswire)
2024-08-27 20:00
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors(Globenewswire)
2024-08-27 08:00
Korro to Participate in Upcoming September Investor and Scientific Conferences(GlobeNewswire)
2024-08-26 20:00
Korro to Participate in Upcoming September Investor and Scientific Conferences(Globenewswire)
2024-08-13 16:01
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates(GlobeNewswire)
2024-08-13 04:01
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-07-01 08:00
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes(GlobeNewswire)
2024-06-30 20:00
Korro Joins the Russell 2000 , Russell 3000 , and Russell Microcap Indexes(Globenewswire)
2024-06-25 00:53
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023(Investorplace)
2024-05-30 16:01
Korro to Participate in Upcoming June Investor and Scientific Conferences(GlobeNewswire)
2024-05-30 04:01
Korro to Participate in Upcoming June Investor and Scientific Conferences(Globenewswire)
2024-05-20 14:30
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference(GlobeNewswire)
2024-05-20 02:30
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.